Cargando…

Galactokinase deficiency: lessons from the GalNet registry

PURPOSE: Galactokinase (GALK1) deficiency is a rare hereditary galactose metabolism disorder. Beyond cataract, the phenotypic spectrum is questionable. Data from affected patients included in the Galactosemias Network registry were collected to better characterize the phenotype. METHODS: Observation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubio-Gozalbo, M. Estela, Derks, Britt, Das, Anibh Martin, Meyer, Uta, Möslinger, Dorothea, Couce, M. Luz, Empain, Aurélie, Ficicioglu, Can, Juliá Palacios, Natalia, De Los Santos De Pelegrin, Mariela M., Rivera, Isabel A., Scholl-Bürgi, Sabine, Bosch, Annet M., Cassiman, David, Demirbas, Didem, Gautschi, Matthias, Knerr, Ina, Labrune, Philippe, Skouma, Anastasia, Verloo, Patrick, Wortmann, Saskia B., Treacy, Eileen P., Timson, David J., Berry, Gerard T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790741/ https://www.ncbi.nlm.nih.gov/pubmed/32807972 http://dx.doi.org/10.1038/s41436-020-00942-9

Ejemplares similares

Galactose epimerase deficiency: lessons from the GalNet registry
por: Derks, Britt, et al.
Publicado: (2022)

The natural history of classic galactosemia: lessons from the GalNet registry
por: Rubio-Gozalbo, M. E., et al.
Publicado: (2019)

[(13)C]‐galactose breath test in a patient with galactokinase deficiency and spastic diparesis
por: Ficicioglu, Can, et al.
Publicado: (2021)

Sugar recognition by human galactokinase
por: Timson, David J, et al.
Publicado: (2003)

Comparative modeling and genomics for galactokinase (Gal1p) enzyme
por: Sharma, Ashwani, et al.
Publicado: (2011)

Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia
por: Mackinnon, Sabrina R., et al.
Publicado: (2021)

Expression, purification, crystallization and preliminary X-ray diffraction analysis of galactokinase from Pyrococcus horikoshii. Erratum
por: Inagaki, Eiji, et al.
Publicado: (2006)

A novel c.-22T>C mutation in GALK1 promoter is associated with elevated galactokinase phenotype
por: Park, Hyung-Doo, et al.
Publicado: (2009)

International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up
por: Welling, Lindsey, et al.
Publicado: (2016)

Ornithine transcarbamylase deficiency: A diagnostic odyssey
por: Knerr, Ina, et al.
Publicado: (2022)

Abnormal N‐glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake
por: Treacy, Eileen P., et al.
Publicado: (2021)

The hypergonadotropic hypogonadism conundrum of classic galactosemia
por: Derks, Britt, et al.
Publicado: (2022)

THE ASSAY OF GALACTOKINASE AND GALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE ACTIVITY IN HUMAN ERYTHROCYTES : A PRESUMED TEST FOR HETEROZYGOUS CARRIERS OF THE GALACTOSEMIC DEFECT
por: Robinson, Arthur
Publicado: (1963)

THE ASSAY OF GALACTOKINASE AND GALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE ACTIVITY IN HUMAN ERYTHROCYTES : A PRESUMED TEST FOR HETEROZYGOUS CARRIERS OF THE GALACTOSEMIC DEFECT
por: Robinson, Arthur
Publicado: (1963)

Fertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions
por: Colhoun, Hugh-Owen, et al.
Publicado: (2018)

A retrospective study on disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria
por: Herle, Marion, et al.
Publicado: (2021)

Recombinant feline corona virus-S protein; expressed as galactokinase fusion protein and useful as reconbinant vaccine, therapeutic and diagnostic agents for feline-infectious-peritonitis virus
Publicado: (1992)

Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD)
por: Karall, Daniela, et al.
Publicado: (2015)

From common to rare: repurposing of bempedoic acid for the treatment of glycogen storage disease type 1
por: Das, Anibh M.
Publicado: (2023)

Fertility preservation in female classic galactosemia patients
por: van Erven, Britt, et al.
Publicado: (2013)

100 years of inherited metabolic disorders in Austria—A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021
por: Ramoser, Gabriele, et al.
Publicado: (2021)

Ten‐year retrospective review (2003‐2013) of 56 inpatient admissions to stabilize elevated phenylalanine levels
por: Clark, Anne, et al.
Publicado: (2019)

Mechanism of Action of Ketogenic Diet Treatment: Impact of Decanoic Acid and Beta—Hydroxybutyrate on Sirtuins and Energy Metabolism in Hippocampal Murine Neurons
por: Dabke, Partha, et al.
Publicado: (2020)

Cystathionine beta synthase deficiency and brain edema associated with methionine excess under betaine supplementation: Four new cases and a review of the evidence
por: Schwahn, Bernd C., et al.
Publicado: (2020)

Gaucheroma of Mesenteric Lymph Nodes and Their Ultrasound Appearance: A Case Report
por: Saliba, Thomas, et al.
Publicado: (2023)

Profiling of intracellular metabolites produced from galactose and its potential for galactosemia research
por: van Weeghel, Michel, et al.
Publicado: (2018)

Review of miglustat for clinical management in Gaucher disease type 1
por: Ficicioglu, Can
Publicado: (2008)

New tools and approaches to newborn screening: ready to open Pandora's box?
por: Ficicioglu, Can
Publicado: (2017)

The Editor’s Choice for Issue 2, Volume 7
por: Ficicioglu, Can
Publicado: (2021)

Mudd’s disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes
por: Chien, Yin-Hsiu, et al.
Publicado: (2015)

Cross-sectional observational study of 208 patients with non-classical urea cycle disorders
por: Rüegger, Corinne M., et al.
Publicado: (2013)

Inborn Errors of Energy Metabolism Associated with Myopathies
por: Das, Anibh M., et al.
Publicado: (2010)

Management of late onset urea cycle disorders—a remaining challenge for the intensivist?
por: Redant, S., et al.
Publicado: (2021)

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
por: Derks, Terry G. J., et al.
Publicado: (2021)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017)

The challenges of classical galactosemia: HRQoL in pediatric and adult patients
por: Hermans, Merel E., et al.
Publicado: (2023)

Hydroxyurea: comparison of cytotoxic and antimitotic activities against human lymphocytes in vitro.
por: Timson, J.
Publicado: (1969)

Provider Perspectives on the Impact of the COVID-19 Pandemic on Newborn Screening
por: Gold, Jessica I., et al.
Publicado: (2021)

Glutaric aciduria type 1: Diagnosis, clinical features and long‐term outcome in a large cohort of 34 Irish patients
por: Healy, Lydia, et al.
Publicado: (2022)

Giving samples or “getting checked”: measuring conflation of observational biospecimen research and clinical care in Latino communities
por: Knerr, Sarah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qbcc3sf5tfafo1osajua7r23n1